Current and historical daily PE Ratio for EXMceuticals Inc (
FRA:9OM1
) from 2015 to May 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. EXMceuticals stock (FRA:9OM1) PE ratio as of May 25 2024 is 0.
More Details
EXMceuticals Inc (FRA:9OM1) PE Ratio (TTM) Chart
EXMceuticals Inc (FRA:9OM1) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1151
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| EXMceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-26 | At Loss | 2023-10-10 | At Loss |
| 2023-12-13 | At Loss | 2023-10-09 | At Loss |
| 2023-12-12 | At Loss | 2023-10-06 | At Loss |
| 2023-12-11 | At Loss | 2023-10-05 | At Loss |
| 2023-12-08 | At Loss | 2023-10-04 | At Loss |
| 2023-12-07 | At Loss | 2023-10-03 | At Loss |
| 2023-12-06 | At Loss | 2023-10-02 | At Loss |
| 2023-12-05 | At Loss | 2023-09-29 | At Loss |
| 2023-12-04 | At Loss | 2023-09-28 | At Loss |
| 2023-12-01 | At Loss | 2023-09-27 | At Loss |
| 2023-11-30 | At Loss | 2023-09-26 | At Loss |
| 2023-11-29 | At Loss | 2023-09-25 | At Loss |
| 2023-11-28 | At Loss | 2023-09-22 | At Loss |
| 2023-11-27 | At Loss | 2023-09-21 | At Loss |
| 2023-11-24 | At Loss | 2023-09-20 | At Loss |
| 2023-11-23 | At Loss | 2023-09-19 | At Loss |
| 2023-11-22 | At Loss | 2023-09-18 | At Loss |
| 2023-11-21 | At Loss | 2023-09-15 | At Loss |
| 2023-11-20 | At Loss | 2023-09-14 | At Loss |
| 2023-11-17 | At Loss | 2023-09-13 | At Loss |
| 2023-11-16 | At Loss | 2023-09-12 | At Loss |
| 2023-11-15 | At Loss | 2023-09-11 | At Loss |
| 2023-11-14 | At Loss | 2023-09-08 | At Loss |
| 2023-11-10 | At Loss | 2023-09-07 | At Loss |
| 2023-11-09 | At Loss | 2023-09-06 | At Loss |
| 2023-11-08 | At Loss | 2023-09-05 | At Loss |
| 2023-11-07 | At Loss | 2023-09-04 | At Loss |
| 2023-11-06 | At Loss | 2023-09-01 | At Loss |
| 2023-11-03 | At Loss | 2023-08-31 | At Loss |
| 2023-11-02 | At Loss | 2023-08-30 | At Loss |
| 2023-11-01 | At Loss | 2023-08-29 | At Loss |
| 2023-10-30 | At Loss | 2023-08-28 | At Loss |
| 2023-10-27 | At Loss | 2023-08-25 | At Loss |
| 2023-10-26 | At Loss | 2023-08-24 | At Loss |
| 2023-10-25 | At Loss | 2023-08-22 | At Loss |
| 2023-10-24 | At Loss | 2023-08-21 | At Loss |
| 2023-10-23 | At Loss | 2023-08-18 | At Loss |
| 2023-10-20 | At Loss | 2023-08-17 | At Loss |
| 2023-10-19 | At Loss | 2023-08-16 | At Loss |
| 2023-10-18 | At Loss | 2023-08-15 | At Loss |
| 2023-10-17 | At Loss | 2023-08-14 | At Loss |
| 2023-10-16 | At Loss | 2023-08-11 | At Loss |
| 2023-10-13 | At Loss | 2023-08-10 | At Loss |
| 2023-10-12 | At Loss | 2023-08-09 | At Loss |
| 2023-10-11 | At Loss | 2023-08-08 | At Loss |
EXMceuticals Inc (FRA:9OM1) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
EXMceuticals Inc
NAICS : 325411
SIC : 3741
Compare
Compare
Traded in other countries / regions
EXM.Canada9OM1.Germany IPO Date
2015-05-22Description
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers